DrugDosage and routeAdverse effectsConsiderations
Antipsychotics
DroperidolIM: 5 to 10 mg as monotherapy or in combination with a benzodiazepine; up to 20 mg daily
IV: 2.5 to 10 mg, may repeat dose every five minutes until acute symptoms are controlled; up to 20 mg daily
No renal adjustment is necessary
Extrapyramidal syndrome, prolonged QT interval, anticholinergic effects, hematologic abnormalities, central nervous system depression, esophageal dysmotility, falls, hyperprolactinemia, neuroleptic malignant syndrome, orthostatic hypotensionFDA boxed warning: increased mortality in older patients with dementia-related psychosis
HaloperidolOral: 0.5 to 1 mg; repeat dose every six hours as needed; up to 30 mg daily
IM/IV: 0.5 to 1 mg; repeat dose every 30 minutes until acute symptoms are controlled; up to 30 mg daily
No renal adjustment is necessary
Extrapyramidal syndrome, prolonged QT interval, anticholinergic effects, hematologic abnormalities, central nervous system depression, esophageal dysmotility, falls, hyperprolactinemia, neuroleptic malignant syndrome, orthostatic hypotensionContraindicated in Parkinson disease, severe central nervous system depression, Lewy body dementia
Atypical antipsychotics
AripiprazoleOral: 2 to 5 mg once daily; up to 15 mg once daily
No renal adjustment is necessary
Extrapyramidal syndrome, prolonged QT interval, anticholinergic effects, hematologic abnormalities, metabolic syndrome, hyperprolactinemia, neuroleptic malignant syndrome, orthostatic hypotensionFDA boxed warning: increased mortality in older patients with dementia-related psychosis
Olanzapine (Zyprexa)Oral: 5 to 10 mg once (or 2.5 mg once daily in patients older than 60 years); up to 20 mg daily
IM: 5 to 10 mg once; may repeat after two to four hours if needed; up to 30 mg daily
No renal adjustment is necessary
Extrapyramidal syndrome, prolonged QT interval, anticholinergic effects, hematologic abnormalities, metabolic syndrome, hyperprolactinemia, neuroleptic malignant syndrome, orthostatic hypotensionFDA boxed warning: increased mortality in older patients with dementia-related psychosis
QuetiapineOral: 12.5 mg twice daily or 25 to 50 mg at bedtime; up to 400 mg daily
No renal adjustment is necessary
Extrapyramidal syndrome, prolonged QT interval, anticholinergic effects, hematologic abnormalities, metabolic syndrome, hyperprolactinemia, neuroleptic malignant syndrome, orthostatic hypotensionRandomized controlled trials comparing effectiveness with haloperidol showed comparable response rates
Risperidone (Risperdal)Oral: 0.5 mg twice daily; up to 6 mg daily
Creatinine clearance of 30 to 60 mL per minute: administer 50% to 75% of the usual dose
Creatinine clearance of 10 to less than 30 mL per minute: administer 50% of the usual dose
Creatinine clearance less than 10 mL per minute: consider an alternative agent
Extrapyramidal syndrome, prolonged QT interval, anticholinergic effects, hematologic abnormalities, metabolic syndrome, hyperprolactinemia, neuroleptic malignant syndrome, orthostatic hypotensionFDA boxed warning: increased mortality in older patients with dementia-related psychosis
ZiprasidoneOral: 20 to 40 mg twice daily with meals; up to 80 mg daily
IM: 10 mg daily; up to 40 mg daily
No renal adjustment is necessary
Extrapyramidal syndrome, prolonged QT interval, anticholinergic effects, hematologic abnormalities, metabolic syndrome, hyperprolactinemia, neuroleptic malignant syndrome, orthostatic hypotensionFDA boxed warning: increased mortality in older patients with dementia-related psychosis
Benzodiazepines
LorazepamOral/IM/IV: 0.5 to 2 mg every four to six hours as needed; up to 10 mg daily
No renal adjustment is necessary
Sleep disturbances, paradoxical excitation, respiratory depression, anterograde amnesia, excessive sedation, confusionMay worsen delirium
Treatment limited by adverse effects
MidazolamIM/IV: 2.5 to 5 mg; up to 20 mg daily
No renal adjustment is necessary
Sleep disturbances, paradoxical excitation, respiratory depression, anterograde amnesia, excessive sedation, confusionIndicated for seizures and alcohol or hypnotic withdrawal
Anesthetics
KetamineIM: 4 to 6 mg per kg; may repeat dose once five to 10 minutes after the initial dose; up to 200 mg daily
IV: 0.5 to 1 mg per kg; may repeat dose once 10 to 25 minutes after initial dose using 2 to 3 mg per kg; up to 500 mg daily
No renal adjustment is necessary
Laryngospasm, increased blood pressure, increased heart rate, cardiac arrhythmia, genitourinary effects, respiratory depressionUse with caution in patients with cardiovascular disease
Antidepressants
TrazodoneOral: 25 to 50 mg once daily at bedtime; up to 300 mg daily
No renal adjustment is necessary
Increased risk of bleeding, cardiac arrhythmias, orthostatic hypotension, serotonin syndrome, suicidal thinking and behaviorMay worsen and prolong delirium symptoms